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 Laser in situ keratomileusis (LASIK) has become the
most frequently used refractive procedure in the world [1],
due to rapid visual recovery and lack of significant pain. More
than one million procedures are estimated to have been per-
formed worldwide [1,2]. This procedure represents a combi-
nation of previously used techniques in refractive surgery. It
involves the use of a microkeratome to create a thin corneal
flap, followed by excimer laser ablation of the corneal stroma
and repositioning of the flap [2]. Corneal lamellar dissection
was first described in 1949 by Barraquer [3] as part of
keratomileusis surgery, and it was later modified to become
an integral component of automated lamellar keratoplasty
(ALK). Corneal excimer laser ablation has been used in
photorefractive keratectomy (PRK) since 1983. Further ad-
vances in excimer laser technology and the development of
safer microkeratomes have allowed lamellar refractive sur-
gery to expand from a surgical technique performed by only a
few experts to a widespread procedure, now performed by the
general ophthalmic surgeon [2,4,5].
The clinical outcome of laser refractive surgery may be
less than ideal for a group of patients because the cornea, as a
biological structure, is subject to individual variation in the
healing response [6]. Variability in wound healing response
among patients is progressively gaining more attention be-
cause it affects the degree of prediction and stability of all
refractive surgical procedures. With the development of mo-
lecular and cellular biology, the understanding of the molecu-
lar basis for this variation is becoming increasingly feasible
[6,7].
The stromal cells secrete an extracellular matrix composed
mainly of collagen fibrils arranged in orthogonal lamellae, and
proteoglycans [8]. Maurice [9] attributed the transparency of
the cornea to the regular spacing of corneal fibrils, and the
corneal proteoglycans play a role in the collagen fibrilogenesis
and matrix assembly. There are strong evidences suggesting
the involvement of proteoglycans in the development and
maintenance of corneal transparency. See reference [10] for a
review on corneal collagen and proteoglycans.
Proteoglycans are macromolecules that have a protein core
with covalently linked glycosaminoglycan side chains [11].
In many species, the predominant corneal glycosaminogly-
cans are dermatan sulfate and keratan sulfate, with smaller
amounts of heparan sulfate. The main corneal extracellular
matrix proteoglycans belong to the small leucine-rich family
of proteins (SLRP). Some members of this family are known
to regulate collagen fibrillogenesis [10]. In 1992, a cDNA clone
encoding the lumican core protein of a chick corneal keratan
sulfate proteoglycan [12] was obtained, and the bovine [13]
and human [14] lumican core proteins were cloned later. Two
other keratan sulfate proteoglycans, keratocan and mimecan
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142(or osteoglycin), were cloned from the bovine cornea [15].
Although expressed in other tissues, lumican, keratocan, and
mimecan are glycosylated only in the cornea with sulfated
keratan sulfate chains. The crucial role of lumican in the regu-
lation of collagen assembly into fibrils was established in stud-
ies on mice with bilateral corneal opacit that were homozy-
gous for a null mutation in lumican [16]. Furthermore, it was
shown that mimecan-deficient mice have thicker collagen
fibrils in both corneal and skin preparations [17].
Nonglycosylated core protein of lumican is as effective as the
intact proteoglycan in inhibiting fibrillogenesis in vitro [18],
but the glycosylation is important to the corneal transparency
process [19].
The main chick corneal dermatan sulfate proteoglycan
was identified as decorin [20]. It was shown that synthesis of
nonglycosylated decorin in avian cornea leads to disruption
in lamellar organization, suggesting that dermatan sulfate
proteoglycans are not involved in the regulation of collagen
fibril diameter, but are important to fibril-fibril spacing and
lamellar cohesiveness [21]. Furthermore, in corneal explants
from embryonic chicken, an increased synthesis of keratan
sulfate proteoglycan and a decreased synthesis of dermatan
sulfate proteoglycan coincided with the onset of tissue trans-
parency, again suggesting a correlation between proteoglycan
composition and corneal transparency [21].
The main heparan sulfate proteoglycans found in cornea
are perlecan [22], a basement membrane proteoglycan, and
syndecan, a cell surface proteoglycan expressed mainly by
epithelial cells [23,24].
The aim of the present study was to evaluate the effects
of LASIK on proteoglycan biosynthesis and collagen organi-
zation in human cornea explants, in comparison to paired con-
trols.
METHODS
Materials:  Keratanase (from Pseudomonas species) [25], Ham
F-12 culture medium, fetal bovine serum, and papain were
purchased from Sigma Chemical Co., Inc. (St. Louis, MO).
Chondroitinases AC and B, and heparitinase II (from Flavobac-
terium heparinum) were prepared by methods previously de-
scribed in reference [26]. Agarose (standard, low Mr) was pur-
chased from Bio-Rad Laboratories (Richmond, CA).
Acrylamide, N,N-methylenebisacrylamide, N,N,N’,N’-tetram-
ethylenediamine, 1,3-diaminopropane, and ethylenediamine
were from Aldrich Chemical Co., Inc. (Milwaukee, WI).
H2
35SO4 (carrier free) was purchased from Instituto de Energia
Nuclear (São Paulo, SP, Brazil). Ultima Gold liquid scintilla-
tion cocktail was purchased from Packard Instruments Co.,
Inc. (Meriden, CT), and 2,5-diphenyloxazole (PPO) was from
Beckman Instruments, Inc. (Fullerton, CA).
Tissue Source:  We obtained 24 human corneoscleral but-
tons from 12 donors, aged between 20 and 75 years, from
Banco de Olhos do Hospital São Paulo (São Paulo, SP, Bra-
zil). Only eyes from donors who provided specific consent
for research purposes and with a contraindication for trans-
plantation were included. The eyes were stored at 4 °C for a
maximum of 48 h postmortem, in a wet chamber containing 4
mg/ml gentamycin in phosphate buffered saline (PBS). De-
tailed information about characteristics of the donors and cor-
neal specimens is provided in Table 1.
All 24 corneoscleral specimens (LASIK [n=12]; controls
[n=12]) were evaluated for gross abnormalities with a slit lamp
(BP 900; Haag Streit, Switzerland), using direct and indirect
illumination. None of the 12 donors had any history of cor-
neal surgery, and no corneal pathologies were found.
Methods for obtaining and handling of human tissue were
humane, and the tenets of the Declaration of Helsinki were
followed. Informed consent was obtained from each donor’s
family after explanation of the nature and possible conse-
quences of the study.
Surgical technique: LASIK:  LASIK is a two-step surgi-
cal technique for the performance of a refractive corneal sur-
gery. The first step consists of using the microkeratome to
create a partial thickness corneal flap. The microkeratome
consists of two components: a ring, which is applied to the
globe and can harden it by creating a vacuum, and an oscillat-
ing blade, which fits onto the vacuum ring and cuts a partial
thickness corneal flap. The cut is incomplete, leaving a small
hinge, which allows the surgeon to lift the flap, treat the cor-
neal stroma with the excimer laser, and replace the flap with-
out suturing at its original location [2]. The second step uses
the excimer laser, in the same manner as in PRK.
Excimer laser photoablation was performed with a fly-
ing-spot laser (LADAR Vision® System; Summit Autonomous
Technologies, Orlando, FL), with repetition rate of approxi-
mately 55 pulses per second, a spot size of 0.8-0.9 mm, an
average fluence of 180-240 mJ/cm2, and a pulse energy of
2.4-3.0 mJ. The corneas received a 6.0 mm ablation zone di-
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TABLE 1. DEMOGRAPHICS OF LASIK AND CONTROL CORNEAS
LASIK was performed in 12 corneoscleral buttons from 12 donors.
The 12 contralateral corneoscleral buttons were kept intact and used
as controls.
143ameter, 6.0 diopter myopic correction to a theoretical stromal
ablation depth of 68.3 mm. All surgeries were performed by
the same surgeon. For each eye pair, one cornea was submit-
ted to LASIK, and the other was used as a matched control.
LASIK was performed in 12 corneas from 12 donors. The
ocular globes were secured in an ocular globe holder. A hinged
flap was created with a microkeratome (Hansatome; B&L,
Rochester, NY) with a 160 head and 8.5 ring, and excimer
laser photoablation was immediately performed with a flying
spot laser (Summit Autonomous Technologies, LADAR Vi-
sion® System). The stromal bed was then irrigated with sa-
line solution, and finally the flap was folded back onto the
cornea. The other 12 contralateral eyes were kept intact and
used as controls.
Tissue culture and radioisotope labeling of corneas:  Af-
ter the surgery, the corneas were excised under sterile condi-
tions from the eyes, leaving 1.5 mm scleral rims preserved.
The corneas were then washed with 5 ml of a 4 mg/ml
gentamycin solution in PBS, and immediately placed in 12 ml
of HAM F-12 nutrient mixture supplemented with 10.000 U
of penicillin and 100 mg of streptomycin, containing 100 mCi/
ml 35S-sulfate for the metabolic labeling of proteoglycans. The
corneas were labeled with 35S-sulfate for 24 h at 37 °C in 2.5%
CO2 atmosphere. After 35S-sulfate incorporation, the corneas
were trimmed free of the scleral rims, and the proteoglycans
were extract and analyzed. The peripheral cornea surround-
ing the LASIK scar was included in the proteoglycan mea-
surement.
Extraction, identification, and quantification of
proteoglycans and glycosaminoglycans:  After 24 h incuba-
tion, the corneal explants were halved. One half was used for
proteoglycan extraction, and the other was used for
histophatological and birefringence analysis. For proteolgycan
extraction, the corneal explant fragments were weighed, cut
in small pieces (<0.5 mm), and suspended in 4 M guanidine
hydrochloride (GuHCl) in 0.5 sodium acetate buffer, pH 5.8.
After overnight incubation at 4 °C with shaking, debris was
removed by centrifugation and the proteoglycans were pre-
cipitated by the addition of ethanol (3 volumes) to the super-
natant. Subsequently, the precipitates formed were collected
by centrifugation, washed with 80% ethanol, and dried. The
dried material was resuspended in 100 µl of distilled water
and analyzed for proteoglycans by a combination of agarose
gel electrophoresis and enzymatic degradation with specific
glycosaminoglycan lyases, using a technique described in ref-
erence [27]. For the analysis of glycosaminoglycans, the
proteoglycans were submitted to proteolysis with papain (2
mg/ml in 0.06 M phosphate-cysteine buffer, pH 6.5, contain-
ing 20 mM EDTA-1 ml of solution per 100 mg of tissue wet
weight) using a previously described technique [27,28]. The
proteoglycans and their degradation products were fixed on
the gel with cetyltrimethylammonium bromide and stained
with toluidine blue. The 35S-sulfate labeled compounds were
visualized by exposure of the agarose gel slabs (after fixation,
drying, and staining) to a Packard Cyclone™ Storage Phos-
phor System by 1-3 days. For quantification, they were scraped
off the agarose gels and counted in a Beckman 6800 liquid
scintillation spectrophotometer, using Ultima Gold LSC-Cock-
tail [29]. The quantitative results were always corrected for
35S-decay.
Histopathology and birefringence microscopy:  Corneal
halves were fixed in paraformaldehyde (paraformaldehyde in
0.05 M phosphate-buffered saline-PBS, pH 7.4) for 4 h at room
temperature and then rinsed in phosphate buffer. The corneas
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Figure 1. Agarose gel electrophoresis of proteoglycans extracted from human corneal explants.  The left (L) cornea of each pair was submitted
to LASIK, and the right (R) cornea was its matched control. The corneal explants were maintained under tissue culture conditions for 24 h in
the presence of 35S-sulfate for the metabolic labeling of proteoglycans. The proteoglycans were extracted as described in Methods, and
aliquots (5 µl) were submitted to agarose gel electrophoresis, as also described in Methods. The proteoglycans were fixed in the gel and stained
by toluidine blue (A), and the 35S-labeled proteoglycans were localized by radioautography (B). In the images, S indicates a mixture of
standard glycosaminoglycans containing chondroitin sulfate (CS), dermatan sulfate (DS), and heparan sulfate (HS), 5 µg each. KS indicates
keratan sulfate. The numbers 1, 3, 9, and 12 refer to the corneal pairs described in Table 1.
144were dehydrated in graded alcohol washes and embedded in
paraffin. Ultra-thin sections were cut on a microtome (5 µm)
and stained with hematoxylin-eosin (H&E) for standard mor-
phology [30].
For fluorescence microscopy with DAPI, the fixed tissue
fragments were rinsed with PBS, embedded in tissue freezing
medium, and stored at -20 °C. Cryostat cross-sections were
taken from the corneal central area, air dried and stained with
DAPI (1:1000 dilution in PBS) for 5 min to localize cell nu-
clei. Sections were analyzed under conventional fluorescence
microscopy or confocal microscopy [31].
For birefringence analysis, 8 µm sections of human cor-
neal buttons were used after rehydration. All observations were
carried out with transmitted polarized light using a Zeiss mi-
croscope (40X). The optical retardation was measured by
means of a quarter-wave plate at a wavelength of 546 µm [32].
The corneas were examined with polarized light microscopy
24 h after LASIK. The Sènarmont compensator is connected
to the light microscope, so the anisotropic specimen (the hu-
man cornea) is oriented in a subtractive position that at some
tilt angle extinction occurs, provided the compensator’s range
is sufficient for the sample. Compensators consist of thin-sec-
tions of minerals (e.g., quartz, calcite, gypsum/selenite, mica,
etc.), or polymer film equivalents, whose thickness and opti-
cal orientation are carefully controlled so as to provide known
values of retardation and known direction of high and low
refractive indices. When introduced into the light path of a
polarizing microscope, these known retardation values and
refractive index directions are superimposed on an unknown
anisotropic specimen and, by noting the resultant effects (ad-
dition or subtraction of retardation, etc.), give valuable identi-
fying characteristics of the sample. The specific axis and mag-
nitude of the cornea collagen fibrils is determined by first
imaging the cornea without compensation. However, in un-
compensated scans, a nonuniform retardation pattern is present.
The statistical significance was calculated using analysis of
variance between groups (ANOVA).
RESULTS
 Figure 1 shows a representative electrophoresis of
proteoglycans extracted from control (right, R) and LASIK-
treated (left, L) corneal explants, stained with toluidine blue
(total proteoglycans) and detected by radioautography of the
agarose gel slabs (metabolically labeled 35S-proteoglycans,
synthesized during the last 24 h). The main labeled band, ob-
served in all samples, migrated slightly less than the standard
heparan sulfate. A minor band of faster migration was observed
in some samples (2 and 4 in Figure 1). The total amounts of
proteoglycans extracted for each cornea pair were roughly the
same, based on toluidine blue staining, indicating that no varia-
tions occurred in the extraction yields. The 35S-labeling was
found to be greatly decreased in LASIK-treated corneas (see
radioautogram, “R” versus “L” for each pair).
Figure 2 shows the individual paired results. A decrease
in 35S-sulfate incorporation in proteoglycans was observed in
all cases after LASIK.
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Figure 2. Effect of LASIK upon proteoglycan synthesis by human corneal explants.  The experiments were performed as described in Figure
1, except that individual data are presented. The numbers in the insert box refer to the corneal pairs described in Table 1, and each point is the
mean value of three determinations.
145In order to check if the biosynthesis of all proteoglycans
was affected, the glycosaminoglycan chains were released from
the protein cores by proteolysis. They were identified by a
combination of agarose gel electrophoresis and enzymatic
degradation with specific glycosaminoglycan lyases, as de-
scribed in Methods.
The electrophoretic migration of the glycosaminoglycan
chains released from the core proteins by proteolysis is shown
in Figure 3. Upon incubation of the proteoglycans with pa-
pain, the band(s) corresponding to proteoglycans completely
disappeared, and one band, migrating as dermatan sulfate and
keratan sulfate, appeared upon toluidine blue staining. Never-
theless, on radioautogram, a second band, migrating as heparan
sulfate, could also be detected. Chondroitin sulfate was not
found.
To confirm the glycosaminoglycan identification, these
compounds were incubated with specific glycosaminoglycan
lyases. Upon the action of F.  heparinum chondroitinase B,
dermatan sulfate was degraded to oligosaccharides and disac-
charides that were not fixed in the gel [33]. The band migrat-
ing as heparan sulfate disappeared upon the action of
heparitinase II, and upon the action of keratanase, keratan sul-
fate was digested. F.  heparinum chondroitinase AC had no
effect upon corneal glycosaminoglycan, confirming that chon-
droitin sulfate was not present and corneal dermatan sulfate is
predominantly a L-iduronic acid containing polymer. Figure
4 shows the mean±standard error of all the samples (three
determinations for each sample), obtained after release of the
glycosaminoglycan chains by proteolysis of the 35S-labeled
proteoglycans. The synthesis of all glycosaminoglycans de-
creased after LASIK, but the synthesis of dermatan sulfate
decreased more, leading to a decrease in the relative propor-
tion of this glycosaminoglycan. The degradation products
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Figure 3. Agarose gel electrophoresis of glycosaminoglycans released
by proteolysis from proteoglycans extracted from human corneal
explants after LASIK.  The proteoglycans extracted from pair num-
ber 12 (see Table 1) of human corneal explants underwent proteoly-
sis with papain for release of the glycosaminoglycan chains. Aliquots
of the incubation mixtures were submitted to agarose gel electro-
phoresis. Total proteoglycans (PG) and glycosaminoglycans (GAG)
were stained by toluidine blue (A), and the 35S-labeled glycosami-
noglycans (35S-GAG) were localized by radioautography (B). S: A
mixture of standard glycosaminoglycans containing chondroitin sul-
fate (CS) dermatan sulfate (DS), and heparan sulfate (HS), 5 µg each;
KS, keratan sulfate; PG, intact proteoglycans.
Figure 4. Effect of LASIK upon the synthesis of 35S-dermatan sul-
fate, 35S-keratan sulfate, and 35S-heparan sulfate by human corneal
explants.  Shown are the 35S-sulfate incorporation (A; cpm,
mean±standard error, three determinations for each sample) and the
ratio between LASIK and control (B). The identification of each gly-
cosaminoglycan was based on a combination of agarose gel electro-
phoresis and enzymatic degradation with specific glycosaminogly-
can lyases (chondroitinases, keratanase and heparitinase).
Figure 5. Polyacrylamide gel electrophoresis of proteoglycans ex-
tracted from human corneal explants.  Aliquots (5 µl) of proteoglycans
extracted from pair number 1 (see Table 1) of human corneal ex-
plants were submitted to polyacrylamide gel electrophoresis, as de-
scribed in Methods. The gel was stained with coomassie blue (A),
and the 35S-labeled compounds were localized by radioautography
(B). St: molecular weight standard proteins; C: control cornea; L:
LASIK submitted cornea.
146formed after the action of the glycosaminoglycan lyases were
the same for LASIK-treated and control corneas, indicating
that this decrease in 35S-sulfate incorporation is not due to the
synthesis of undersulfated proteoglycans.
Figure 5 shows a representative polyacrylamide gel elec-
trophoresis of the proteoglycans [34] extracted from human
corneal explants after LASIK. This analysis was performed
for all samples. It showed that only low molecular weight
proteoglycans (probably of the decorin/biglycan and lumican/
mimecan families) are present in human cornea, both before
and after LASIK.
Figure 6 shows representative images of H&E and DAPI
staining of corneas submitted to LASIK Figure 6B,D and their
respective controls Figure 6A,C. H&E analysis did not show
any histological alteration after LASIK procedure. DAPI stain-
ing showed a reduction in the number of cell nuclei seems to
occur after LASIK (quantitative data not yet available).
Figure 7 illustrates typical birefringence images of a nor-
mal (Figure 7A,C) and a LASIK-treated cornea (Figure 7B,D),
with dark and bright shadows and also some visible irregu-
larities in the intensity. The corneal collagen fibrils were ori-
ented 45° from the polarizer azimuths, allowing maximum
shining of the fibrils. Sample Figure 7A represents the control
cornea section without compensation. In this human corneal
section, collagen fibrils are seen as either parallel aligned lin-
ear structures or as hexagonal arranged structures. Figure 7C
represents the same corneal micrograph with compensation
to allow the measurements of optical retardation values. In
birefringence images of human corneal sections after LASIK
(Figure 7B,D), only minor differences were observed in col-
lagen fibril alignments when compared to the control cornea.
These differences are evident after obtaining statistical analy-
sis of the quantitative data of optical retardation (Table 2).
Eighty-two measurements were performed for each corneal
group (Control and LASIK) in different regions of corneal
slices. Note that there is a significant decrease in optical val-
ues after LASIK, in comparison to the control group.
DISCUSSION
 The relevance of the regular diameter and distribution of col-
lagen fibrils in stroma for corneal transparency is well docu-
mented [9] as well as the effects of proteoglycans of the SLRP
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Figure 6. Hematoxilin and eosin stain-
ing and fluorescence microscopy for nu-
clei (DAPI) of normal and LASIK-treated
corneal explants.  The experiment was
performed as described in Methods. Ep:
epithelium; If: interface after LASIK; St:
stroma. The scale bar equals 50 µm.
147or “fibrillar” family upon the collagen fibrilogenesis and ex-
tracellular matrix assembly (review in [10]). This is especially
important in processes, such as corneal wound healing, that
could lead to corneal haze and opacity, affecting both tissue
transparency and biomechanics. These are serious concerns
in refractive surgery. The organization of collagen fibrils in
corneal stroma may be assessed by birefringence studies [35-
39], and the proteoglycans present are usually identified by
immunohistochemical studies [40]. Nevertheless, these latter
studies localize all the proteoglycans present in the tissue -
not just those synthesized after the surgical procedures - and
do not permit the structural characterization of proteoglycans.
Biochemical analyses of human corneas after LASIK are
rare [41]. Most studies have been performed in experimental
animals [42-44]. The main proteoglycans of human corneal
stroma are keratan sulfate and dermatan sulfate [25,29,45]. In
our study, the distribution of these compounds was only slightly
altered several months after LASIK [46]. Quantock et al. [47]
showed that sulfated proteoglycans exist in rabbit corneas
healing from lamellar incisions one, two, and three weeks af-
ter the surgical procedure. A recent clinico-pathological study
of two human corneas that had received successful LASIK
treatment reported an active wound-healing response at the
flap-bed interface with identification of periodic acid Schiff-
positive, electron-dense, material three months postoperative
[48].
Our study used human corneas because morphological
investigations have shown that, when this tissue is treated in
vitro with LASIK and then maintained in culture for different
periods, there are striking clinical similarities in LASIK-treated
human and rabbit eyes [49]. As the inflammatory response
after LASIK is low and no inflammatory cells usually enter
the cornea, the in vivo situation is likely to be independent of
systemic factors that are absent in vitro [50,51].
Although several groups have studied the glycosaminogly-
can composition of cornea as well as the biosynthesis of
proteoglycans by rabbit and embryonic chicken corneal ex-
plants [10,12,20], there are few reports concerning human
corneal proteoglycans [14,25,29]. The aim of our study was
to investigate the effects of LASIK upon proteoglycan syn-
thesis by corneal human explants.
We found all human corneal explants were able to incor-
porate 35S-sulfate in proteoglycans, but variations occurred in
the biosynthesis rate among different corneal pairs. These
variations could not be attributed to single features, such as
donor age or time period between donor death and experi-
ments, but are possibly due to the combined interference of
multiple biological conditions.
Nevertheless, in all cases reported here, a marked decrease
in 35S-sulfate incorporation in proteoglycans occurred during
the first 24 h after LASIK, in comparison to their respective
matched controls. This could be due, at least in part, to the
synthesis of undersulfated proteoglycans, but structural analy-
sis with specific glycosaminoglycan lyases revealed no
changes in the sulfation degree. This decrease in label incor-
poration possibly reflects a decrease in the proteoglycan syn-
thesis rate.
The synthesis of all proteoglycans was disturbed, but
dermatan sulfate proteoglycans were the most strongly af-
fected. This is not surprising, since the main proteoglycans
synthesized in a 24 h period by human corneal explants are
dermatan sulfate proteoglycans [25,29]. Keratan sulfate
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Figure 7. Control and LASIK human cornea birefringence images.
The experiment was performed as describe in Methods, with (C,D)
and without (A,B) compensation, for control (A,C) and LASIK-sub-
mitted (B,D) corneal slices. The samples are positioned 45° from the
polarizer azimuth. Ep: epithelium; St: stroma; End: endothelium. The
scale bar is equal to 20 µm.
TABLE 2. OPTICAL RETARDATION MEAN VALUES FOR CONTROL CORNEA
AND CORNEA SUBMITTED TO LASIK, EMBEDDED IN WATER
Statistical significance was calculated by analysis of variance be-
tween groups (ANOVA), as described in the text. Eighty-two mea-
surements were performed for each corneal group (Control and
LASIK) in different regions of corneal slices. In the table, “N” indi-
cates the number of measurements for each group, “OR” indicates
the optical retardation value, and “p” denotes the significance level.
148proteoglycans are synthesized at lower rates, and heparan sul-
fate proteoglycans are minor components of the cornea. More-
over, only low molecular weight proteoglycans were detected.
High molecular weight proteoglycans, such as versican (which
could be synthesized as a healing response), could not be de-
tected.
This conspicuous decrease in proteoglycan synthesis could
be due to epithelial lesion induced by the lamellar cut created
by the microkeratome as well as to stromal photoablation with
excimer laser. However, the 50-60-µm-thick region ablated
by LASIK from the 6 mm central area of the cornea corre-
sponds to about 4% of total stromal tissue, and the decrease in
35S-sulfate incorporation in proteoglycans was close to 90%.
This clearly indicates that the ablated tissue could not be the
only factor responsible for the enormous decrease in
proteoglycan synthesis reported here. Keratocyte cell death
could possibly be also implicated.
Light microscopy did not reveal any traces of corneal
wound healing. Again, this is not surprising since this is an
acute in vitro study. Beneath the flap, corneal collagen bundles
seemed to be uniform and regular, but upon birefringence stud-
ies, some degree of fiber dearrangements could be observed.
There was a decrease in optical retardation values following
LASIK, leading to a decreased molecular corneal organiza-
tion, that may be related to the conspicuous changes in
proteoglycan synthesis.
In conclusion, the data here presented indicate a marked
decrease in proteoglycan synthesis and changes in corneal col-
lagen organization 24 h after in vitro LASIK surgery in hu-
man cornea.
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